Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects

By Zhang Dan   Wang Xiaolin   Yang Man   Wang Guocai   Liu Huichen  

Xenobiotica, Vol. 41, Iss. 6, 2011-06 ,pp. : 511-517

Informa Healthcare

Access to resources Recommend Favorite

Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians

By Kohlrausch Fabiana   Carracedo Ángel   Hutz Mara  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1453-1460

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study

By Vicente Jorge   González-Andrade Fabricio   Soriano Antonia   Fanlo Ana   Martínez-Jarreta Begoña   Sinués Blanca  

Molecular Biology Reports, Vol. 41, Iss. 3, 2014-03 ,pp. : 1267-1272

Springer Publishing Company

Access to resources Recommend Favorite

Functional characterization of promoter region polymorphisms of human CYP2C19 gene

By Satyanarayana Chakradhara Rao Uppugunduri   Devendran Anichavezhi   Satyamoorthy Kapettu   Shewade Deepak   Krishnamoorthy Rajgopal   Chandrasekaran Adithan  

Molecular Biology Reports, Vol. 38, Iss. 6, 2011-08 ,pp. : 4171-4179

Springer Publishing Company

Access to resources Recommend Favorite

Influence of CYP2C19 and ABCB1 polymorphisms on plasma concentrations of lansoprazole enantiomers after enteral administration

By Miura Masatomo   Motoyama Satoru   Hinai Yudai   Niioka Takenori   Endo Masahiro   Hayakari Makoto   Ogawa Jun-ichi  

Xenobiotica, Vol. 40, Iss. 9, 2010-09 ,pp. : 630-636

Informa Healthcare

Access to resources Recommend Favorite